EN DE

Breakthrough Chemistry, Inc (BKTH) Fair Value & Analysis

Industrials · US · Market cap $2.4M

BC Breakthrough Chemistry, Inc logo Breakthrough Chemistry, Inc BKTH · US
Price$0.2200
Fair Value$0.0300
Upside-86.4%
Quality36/100
Watch Breakthrough Chemistry, Inc for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Thin margins · 0.0% net margin
negative free cash flow
Trails peers (1/7)
Narrow moat 23/100
Evidence: Low Range $0.0200 – $0.0500 Share as image

Fair value as of: Jul 15, 2026

From 1 valuation models · updated 26 days ago

Fair value updated Jul 15, 2026, revised from $0.2200 to $0.0300 (−86.4%) since Jun 24, 2026. Share price −19.7% over the past month.

Below-average quality, and screening another 86% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case ($0.0500). The favourable scenario is already priced in.
  • Weak quality (36/100) and above fair value at the same time, the margin of safety is missing on both counts.
  • The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
  • A fairly wide model range ($0.0200 to $0.0500) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$0.8850 $0.0320 Fair Value $0.0300 Apr 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 15, 2026.

How to read this chart

60‑month range $0.0320 – $0.8850 · fair‑value band $0.0200 – $0.0500 · the $0.2200 price screens above the $0.0300 fair value. Dashed = 300-day average. As of Jul 15, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Breakthrough Chemistry, Inc (BKTH) currently trades at $0.2200, while our model-based Fair Value estimate is $0.0300, implying the stock looks roughly 86.4% overvalued today. The Quality Score stands at 36/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).

Trailing-twelve-month revenue stands at $19.2K. Revenue grew 2.9% year over year. Fundamentals as of Jul 15, 2026

Our scenario range runs from $0.0200 (bear case) to $0.0500 (bull case); at $0.2200, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 37% below its 52-week high, currently above its 200-day average. For context, the median of 10 Industrials peers we cover trades at -48% fair-value upside, at -86%, BKTH screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
NCAV (Graham) $0.0200 $0.0300 $0.0500 50
All 1 models by family
Asset-Based
NCAV (Graham) $0.0200 $0.0300 $0.0500 50

Notify me when BKTH reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) $19.2K
Revenue growth (YoY) +2.9%
Free cash flow −$58.8K FY2025
Operating margin -528%
EPS (TTM) $-42.18
Net debt $191K FY2025

Figures from reported company fundamentals · as of Jul 15, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 36/100

Of which business quality 35 · Market factors (momentum, volatility) 58

Profitability 0
Margins and returns on capital today
Quality Growth 92
Are margins and returns improving?
Cashflow 17
Earnings quality: real cash, not paper profit
Fin. Strength 46
Balance sheet, leverage, solvency risk
Investment 50
Disciplined investing over empire-building
Low Volatility 0
Calm price path (market factor)
Momentum 91
Price trend over the last 3–12 months (market factor)
52W Momentum 66
Distance to the 52-week high (market factor)
Net Issuance 33
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Breakthrough Chemistry, Inc. develops compounds and formulations that defy the norms prevalent in chemical industries. The company's chemistry platform offers solutions for food security and spoilage reduction, natural resource conservation, personal hygiene, protective coatings, odor elimination, and chemical neutralization. Breakthrough Chemistry, Inc.

Full company description

Breakthrough Chemistry, Inc. develops compounds and formulations that defy the norms prevalent in chemical industries. The company's chemistry platform offers solutions for food security and spoilage reduction, natural resource conservation, personal hygiene, protective coatings, odor elimination, and chemical neutralization. Breakthrough Chemistry, Inc. was formerly known as Megola, Inc. and changed its name to Breakthrough Chemistry, Inc. in July 2025. The company is based in Bonita Springs, Florida.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Breakthrough Chemistry, Inc reported revenue of $33.8K in FY2025 versus $95.6K in FY2021, a compound −22.9%/yr. Reported net income was −$46.7K in FY2025.

Growth Quality 36/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
$33.8K
Latest YoY
+78.5%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+26.4%
Avg. growth/yr (23Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−3.2%
Revenue −22.9%/yr
FY21 $95.6K
FY22 $16.7K
FY23 $13.8K
FY24 $18.9K
FY25 $33.8K
Net income
FY21 $18.2M
FY22 −$151K
FY23 −$187K
FY24 −$221K
FY25 −$46.7K

BKTH screens 86% overvalued. Compare with Veralto Corporation →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Breakthrough Chemistry, Inc Fair Value". https://www.fairvalue-calculator.com/stock/BKTH

Peer Group

Pollution & Treatment Controls · 91 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 35 · Bottom 25%
Fair Value upside −86% · Bottom 25%
Return on assets 0% · Below median
Net margin (TTM) 0% · Below median
Revenue growth 3% · Above median

Valuation Multiples vs Pollution & Treatment Controls median · lower = cheaper

P/B 5.14× · Pricier than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 0
FUTURE 15 · sector 14
PAST 0 · sector 10
HEALTH 0 · sector 95
DIVIDEND 0 · sector 37

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Pollution & Treatment Controls stocks, each showing price versus our Fair Value estimate (as of Jul 15, 2026).

Stock Price Fair Value vs Fair Value
Veralto Corporation VLTO $94.21 $69.11 -27%
Zurn Elkay Water Solutions Corporation ZWS $47.63 $24.92 -48%
Canmax Technologies Co 300390 ¥57.02 ¥10.41 -82%
CECO Environmental Corp CECO $83.63 $15.19 -82%
Fujian Longking Co 600388 ¥17.58 ¥15.59 -11%
Munters Group MTRS kr 166.60 kr 16.90 -90%
China Conch Venture Holdings 0586 HK$8.83 HK$14.14 +60%
Mega Union Technology Inc 6944 1,005 TWD 539.58 TWD -46%
MayAir Technology (China) Co 688376 ¥96.57 ¥18.80 -81%
Shanghai Emperor of Cleaning Hi-Tech Co 603200 ¥38.97 ¥5.73 -85%

Compare Breakthrough Chemistry, Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Breakthrough Chemistry, Inc (BKTH) overvalued or undervalued?
As of Jul 15, 2026, our model estimates a fair value of $0.0300 versus a price of $0.2200, about −86% (overvalued).
What is the fair value of BKTH?
Our model-based fair value for Breakthrough Chemistry, Inc is $0.0300 (as of Jul 15, 2026), built from audited fundamentals. The current price is $0.2200.
What is the quality score of BKTH?
Breakthrough Chemistry, Inc has a Quality Score of 36/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Breakthrough Chemistry, Inc (BKTH)?
Breakthrough Chemistry, Inc reported trailing-twelve-month revenue of about $19.2K (latest available figure, as of Jul 15, 2026).
What is the net profit margin of BKTH?
The net profit margin of Breakthrough Chemistry, Inc is about 0.0%, meaning it keeps roughly 0.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Breakthrough Chemistry, Inc and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.